Oxyclozanide

Oxyclozanide is a salicylanilide anthelmintic. It is used in the treatment and control of fasciolosis in ruminants primarily sheep and cattle. It is capable of killing all stages of Fasciola hepatica from newly ingested immature forms to fully mature adult flukes.
History[edit]
Oxyclozanide was first developed in the 1960s by Wellcome Research Laboratories as a treatment for fasciolosis. It has since been used worldwide and is considered a safe and effective treatment for this disease.
Pharmacology[edit]
Oxyclozanide works by uncoupling oxidative phosphorylation in flukes, this causes a disruption in the fluke's energy metabolism, leading to paralysis and death of the parasite. It is effective against both mature and immature flukes, as well as against some other gastrointestinal roundworms.
Usage[edit]
Oxyclozanide is administered orally, usually in the form of a drench. The recommended dosage is 10 mg/kg body weight for sheep and 15 mg/kg for cattle. It is not recommended for use in animals with impaired liver function or for pregnant ewes during the first trimester of pregnancy.
Side Effects[edit]
Side effects are rare but can include salivation, diarrhea, and in rare cases, death. These side effects are usually associated with overdosage.
Resistance[edit]
Resistance to oxyclozanide has been reported in some countries, including Ireland and the Netherlands. This resistance is believed to be due to the overuse of the drug, and the lack of rotation with other anthelmintics.
See Also[edit]
This veterinary medicine related article is a stub. You can help WikiMD by expanding it.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
